Is a complete MLTX research report available?

No complete published report is available for MoonLake Immunotherapeutics (MLTX) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

MoonLake Immunotherapeutics (MLTX)

NASDAQ: MLTX · USD

$12.3

+0.39 (+3.3%)· Recorded snapshot

Market cap	1B
Net income (ttm)	-263.7M
EPS (ttm)	-$3.81
Shares out	85.1M
Volume	1,035,378
Beta	1.08

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -263.7M
EPS (ttm): -$3.81
Market cap: 1B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Mantener

Metric	Value
Amount currency	USD
CIK code	0001821586
Company name	MoonLake Immunotherapeutics
Country	Switzerland
Country code	US
CUSIP number	61559X104
Earnings date	2026-11-09
Earnings time	bmo
Employees	130
Employees change	30
Employees growth	30%
Enterprise value	$613M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2021
Industry	Biotechnology
Is primary listing	Yes
Is SPAC	No
ISIN number	KY61559X1045
Last 10-K release date	2026-02-25
Last earnings date	2026-08-10
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$1B
Market cap category	Small-Cap
Next earnings date	2026-11-09
Options	Yes
Price	$12.32
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	MLTX
Tags	pharmaceuticals
Website	https://www.moonlaketx.com

Metric

Value

Amount currency

USD

CIK code

0001821586

Company name

MoonLake Immunotherapeutics

Country

Switzerland

Country code

CUSIP number

61559X104

Earnings date

2026-11-09

Earnings time

bmo

Employees

130

Employees change

Employees growth

30%

Enterprise value

$613M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2021

Industry

Biotechnology

Is primary listing

Yes

Is SPAC

ISIN number

KY61559X1045

Last 10-K release date

2026-02-25

Last earnings date

2026-08-10

Last refreshed

2026-10-28

Last stock split type

Never

Market cap

$1B

Market cap category

Small-Cap

Next earnings date

2026-11-09

Options

Yes

Price

$12.32

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

MLTX

Tags

pharmaceuticals

Website

https://www.moonlaketx.com

Metric	Value
Earnings yield	-30.96%
FCF / EV yield	-36.99%
FCF yield	-21.56%
Forward EV/Sales	2,314.68x
Forward P/S	3,970.57x
P/B ratio	2.33x
Price / tangible book value	2.44x
Sector forward P/E	23.56x
Sector P/E	50.08x

Metric

Value

Earnings yield

-30.96%

FCF / EV yield

-36.99%

FCF yield

-21.56%

Forward EV/Sales

2,314.68x

Forward P/S

3,970.57x

P/B ratio

2.33x

Price / tangible book value

2.44x

Sector forward P/E

23.56x

Sector P/E

50.08x

Metric	Value
Profit per employee	$-2M
ROA	-32.44%
ROCE	-50.77%
ROE	-67.47%
ROIC	-34.81%

Metric

Value

Profit per employee

$-2M

ROA

-32.44%

ROCE

-50.77%

ROE

-67.47%

ROIC

-34.81%

Metric	Value
EPS growth quarters	1
EPS growth years	0
Net income growth years	0
Revenue growth years	0

Metric

Value

EPS growth quarters

EPS growth years

Net income growth years

Revenue growth years

Metric	Value
Capital expenditures	$0
Depreciation and amortization	$3.2M
EBIT	$-268.3M
EBITDA	$-265.1M
EPS	$-3.81
FCF per share	$-2.65
Financing cash flow	$338.1M
Free cash flow	$-225.2M
Free cash flow minus SBC	$-248.4M
Income taxes	$1.1M
Investing cash flow	$58.9M
Net borrowing	$24.5M
Net cash flow	$171.2M
Net income	$-263.7M
Operating cash flow minus SBC	$-248.4M
Operating income	$-268.3M
Stock-based compensation	$23.2M

Metric

Value

Capital expenditures

Depreciation and amortization

$3.2M

EBIT

$-268.3M

EBITDA

$-265.1M

EPS

$-3.81

FCF per share

$-2.65

Financing cash flow

$338.1M

Free cash flow

$-225.2M

Free cash flow minus SBC

$-248.4M

Income taxes

$1.1M

Investing cash flow

$58.9M

Net borrowing

$24.5M

Net cash flow

$171.2M

Net income

$-263.7M

Operating cash flow minus SBC

$-248.4M

Operating income

$-268.3M

Stock-based compensation

$23.2M

Metric	Value
Book value per share	$5.12
Debt / equity	0.24
Interest coverage	-26.59
Long-term assets	$3.9M
Long-term liabilities	$100.4M
Net cash (debt)	$435.5M
Net cash / market cap	41.7%
Net cash growth	24.67%
Net debt / equity	-1.02
Piotroski F-Score	1
Property, plant and equipment	$2.6M
Shareholders' equity	$428.2M
Tangible book value	$428.2M
Tangible book value per share	$5.12
Total assets	$573.9M
Total cash	$537M
Total debt	$101.5M
Total liabilities	$145.8M
WACC	9.97%

Metric

Value

Book value per share

$5.12

Debt / equity

0.24

Interest coverage

-26.59

Long-term assets

$3.9M

Long-term liabilities

$100.4M

Net cash (debt)

$435.5M

Net cash / market cap

41.7%

Net cash growth

24.67%

Net debt / equity

-1.02

Piotroski F-Score

Property, plant and equipment

$2.6M

Shareholders' equity

$428.2M

Tangible book value

$428.2M

Tangible book value per share

$5.12

Total assets

$573.9M

Total cash

$537M

Total debt

$101.5M

Total liabilities

$145.8M

WACC

9.97%

Metric	Value
Current assets	$570M
Current liabilities	$45.4M
Current ratio	12.56
Net working capital	$-11.1M
Quick ratio	11.98
Working capital	$524.6M

Metric

Value

Current assets

$570M

Current liabilities

$45.4M

Current ratio

12.56

Net working capital

$-11.1M

Quick ratio

11.98

Working capital

$524.6M

Metric	Value
Buyback yield / dilution	-9.53%
Dividend yield	0%
Shareholder yield	-9.53%

Metric

Value

Buyback yield / dilution

-9.53%

Dividend yield

Shareholder yield

-9.53%

Metric	Value
150-day SMA	$16.40
1D price change	3.27%
1M price change	2.33%
1M total return	2.33%
1W price change	15.68%
1W total return	15.68%
1Y price change	22.34%
1Y return CAGR	22.36%
1Y total return	22.34%
20-day SMA	$10.97
200-day SMA	$16.52
3M price change	-38.03%
3M total return	-38.03%
3Y price change	-75.35%
3Y return CAGR	-37.29%
3Y total return	-75.35%
50-day SMA	$12.69
50-day SMA vs 200-day SMA	50under200
52-week high	$23.29
52-week high date	2026-06-22
52-week low	$9.37
52-week low date	2025-10-29
5Y price change	23.2%
5Y return CAGR	4.26%
5Y total return	23.2%
6M price change	-26.88%
6M total return	-26.88%
All-time high	$64.98
All-time high date	2024-02-12
All-time low	$4.25
All-time low date	2022-05-16
Average true range (ATR)	$0.74
Average volume	1.9M
Beta (1Y)	1.55
Beta (2Y)	0.67
Beta (5Y)	1.08
Change from 52-week high	-47.1%
Change from 52-week low	31.48%
Change from all-time high	-81.04%
Change from all-time low	189.88%
Change from open	4.23%
Day's gap	-0.92%
Dollar volume	$12.8M
High price	$12.37
Low price	$11.75
Monthly RSI	38.24
Open price	$11.82
Position in 52-week range	91.94%
Premarket change	2.85%
Premarket close	$11.93
Premarket price	$12.27
Premarket volume	159
Previous close	$11.93
Price vs 150-day SMA	-24.87%
Price vs 20-day SMA	12.31%
Price vs 200-day SMA	-25.4%
Price vs 50-day SMA	-2.9%
Relative volume	0.55
RSI	56.88
Sharpe ratio	0.57
Sharpe ratio (3Y)	0.17
Sharpe ratio (5Y)	0.66
Sortino ratio	1.13
Sortino ratio (3Y)	0.28
Sortino ratio (5Y)	1.01
Volume	1M
Weekly RSI	38.88
YTD price change	-6.53%
YTD total return	-6.53%

Metric

Value

150-day SMA

$16.40

1D price change

3.27%

1M price change

2.33%

1M total return

2.33%

1W price change

15.68%

1W total return

15.68%

1Y price change

22.34%

1Y return CAGR

22.36%

1Y total return

22.34%

20-day SMA

$10.97

200-day SMA

$16.52

3M price change

-38.03%

3M total return

-38.03%

3Y price change

-75.35%

3Y return CAGR

-37.29%

3Y total return

-75.35%

50-day SMA

$12.69

50-day SMA vs 200-day SMA

50under200

52-week high

$23.29

52-week high date

2026-06-22

52-week low

$9.37

52-week low date

2025-10-29

5Y price change

23.2%

5Y return CAGR

4.26%

5Y total return

23.2%

6M price change

-26.88%

6M total return

-26.88%

All-time high

$64.98

All-time high date

2024-02-12

All-time low

$4.25

All-time low date

2022-05-16

Average true range (ATR)

$0.74

Average volume

1.9M

Beta (1Y)

1.55

Beta (2Y)

0.67

Beta (5Y)

1.08

Change from 52-week high

-47.1%

Change from 52-week low

31.48%

Change from all-time high

-81.04%

Change from all-time low

189.88%

Change from open

4.23%

Day's gap

-0.92%

Dollar volume

$12.8M

High price

$12.37

Low price

$11.75

Monthly RSI

38.24

Open price

$11.82

Position in 52-week range

91.94%

Premarket change

2.85%

Premarket close

$11.93

Premarket price

$12.27

Premarket volume

159

Previous close

$11.93

Price vs 150-day SMA

-24.87%

Price vs 20-day SMA

12.31%

Price vs 200-day SMA

-25.4%

Price vs 50-day SMA

-2.9%

Relative volume

0.55

RSI

56.88

Sharpe ratio

0.57

Sharpe ratio (3Y)

0.17

Sharpe ratio (5Y)

0.66

Sortino ratio

1.13

Sortino ratio (3Y)

0.28

Sortino ratio (5Y)

1.01

Volume

Weekly RSI

38.88

YTD price change

-6.53%

YTD total return

-6.53%

Metric	Value
Float	55.5M
Float percentage	65.18%
Shares change (QoQ)	3.71%
Shares change (YoY)	9.53%
Shares held by insiders	7.8%
Shares held by institutions	60.34%
Shares outstanding	85.1M
Short % of float	14.51%
Short % of shares	9.46%
Short ratio	4.7 days

Metric

Value

Float

55.5M

Float percentage

65.18%

Shares change (QoQ)

3.71%

Shares change (YoY)

9.53%

Shares held by insiders

7.8%

Shares held by institutions

60.34%

Shares outstanding

85.1M

Short % of float

14.51%

Short % of shares

9.46%

Short ratio

4.7 days

MoonLake Immunotherapeutics (MLTX)

Price

Financial snapshot

Fair-value bridge

Latest news · MLTX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All MLTX indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on MLTX

Frequently asked questions